Incident adverse events following therapy for acute promyelocytic leukemia

The use of all-trans retinoic acid (ATRA) combined with arsenic trioxide (ATO) with or without cytotoxic chemotherapy is highly effective in acute promyelocytic leukemia (APL) but incident chronic adverse events (AEs) after initiation of therapy are not well understood. We retrospectively analyzed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Peter Geon, Bridgham, Kelly, Chen, Evan C, Vidula, Mahesh K, Pozdnyakova, Olga, Brunner, Andrew M, Fathi, Amir T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993355/
https://www.ncbi.nlm.nih.gov/pubmed/29892554
http://dx.doi.org/10.1016/j.lrr.2018.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993355/
https://www.ncbi.nlm.nih.gov/pubmed/29892554
http://dx.doi.org/10.1016/j.lrr.2018.05.001

Ejemplares similares